375 related articles for article (PubMed ID: 10334542)
41. Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience.
Sierra J; Storer B; Hansen JA; Martin PJ; Petersdorf EW; Woolfrey A; Matthews D; Sanders JE; Storb R; Appelbaum FR; Anasetti C
Bone Marrow Transplant; 2000 Aug; 26(4):397-404. PubMed ID: 10982286
[TBL] [Abstract][Full Text] [Related]
42. Allogeneic bone marrow transplantation with T cell-depleted partially matched related donors for advanced acute lymphoblastic leukemia in children and adults: a comparative matched cohort study.
Fleming DR; Henslee-Downey PJ; Romond EH; Harder EJ; Marciniak E; Munn RK; Messino MJ; Macdonald JS; Bishop M; Rayens MK; Thompson JS; Foon KA
Bone Marrow Transplant; 1996 Jun; 17(6):917-22. PubMed ID: 8807094
[TBL] [Abstract][Full Text] [Related]
43. Effects of chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran.
Alimoghaddam K; Ghaffari H; Foroughi F; Chardouli B; Sanaat Z; Bahar B; Mousavi A; Iravani M; Ghavamzadeh A
Arch Iran Med; 2006 Apr; 9(2):99-103. PubMed ID: 16649348
[TBL] [Abstract][Full Text] [Related]
44. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L
Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394
[TBL] [Abstract][Full Text] [Related]
45. Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients.
Mehta J; Singhal S; Gee AP; Chiang KY; Godder K; Rhee Fv Fv; DeRienzo S; O'Neal W; Lamb L; Henslee-Downey PJ
Bone Marrow Transplant; 2004 Feb; 33(4):389-96. PubMed ID: 14716338
[TBL] [Abstract][Full Text] [Related]
46. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
Ruggeri L; Capanni M; Urbani E; Perruccio K; Shlomchik WD; Tosti A; Posati S; Rogaia D; Frassoni F; Aversa F; Martelli MF; Velardi A
Science; 2002 Mar; 295(5562):2097-100. PubMed ID: 11896281
[TBL] [Abstract][Full Text] [Related]
47. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético.
Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A
Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172
[TBL] [Abstract][Full Text] [Related]
48. Relationship between graft-versus-host disease and graft-versus-leukaemia in partial T cell-depleted bone marrow transplantation.
van der Straaten HM; Fijnheer R; Dekker AW; Nieuwenhuis HK; Verdonck LF
Br J Haematol; 2001 Jul; 114(1):31-5. PubMed ID: 11472341
[TBL] [Abstract][Full Text] [Related]
49. T cell-depleted unrelated donor bone marrow transplantation for acute myeloid leukemia.
Marks DI; Bird JM; Vettenranta K; Hunt L; Green A; Cornish JM; Goulden N; Pamphilon DH; Steward CG; Oakhill A
Biol Blood Marrow Transplant; 2000; 6(6):646-53. PubMed ID: 11128816
[TBL] [Abstract][Full Text] [Related]
50. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
[TBL] [Abstract][Full Text] [Related]
51. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
[TBL] [Abstract][Full Text] [Related]
52. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.
Miller CB; Rowlings PA; Zhang MJ; Jones RJ; Piantadosi S; Keating A; Armitage JO; Calderwood S; Harris RE; Klein JP; Lazarus HM; Linker CA; Sobocinski KA; Weisdorf D; Horowitz MM
Exp Hematol; 2001 Nov; 29(11):1336-46. PubMed ID: 11698130
[TBL] [Abstract][Full Text] [Related]
53. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission.
Oakhill A; Pamphilon DH; Potter MN; Steward CG; Goodman S; Green A; Goulden P; Goulden NJ; Hale G; Waldmann H; Cornish JM
Br J Haematol; 1996 Sep; 94(3):574-8. PubMed ID: 8790160
[TBL] [Abstract][Full Text] [Related]
54. Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia.
Lang P; Handgretinger R; Niethammer D; Schlegel PG; Schumm M; Greil J; Bader P; Engel C; Scheel-Walter H; Eyrich M; Klingebiel T
Blood; 2003 Feb; 101(4):1630-6. PubMed ID: 12393439
[TBL] [Abstract][Full Text] [Related]
55. Unrelated donor bone marrow transplantation for children with acute leukemia.
Davies SM; Wagner JE; Shu XO; Blazar BR; Katsanis E; Orchard PJ; Kersey JH; Dusenbery KE; Weisdorf DJ; McGlave PB; Ramsay NK
J Clin Oncol; 1997 Feb; 15(2):557-65. PubMed ID: 9053477
[TBL] [Abstract][Full Text] [Related]
56. The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell-Depleted Hematopoietic Stem Cell Transplantation.
Aristei C; Carotti A; Palazzari E; Amico L; Ruggeri L; Perrucci E; Falcinelli L; Lancellotta V; Palumbo I; Falzetti F; Aversa F; Merluzzi M; Velardi A; Martelli MF
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):832-839. PubMed ID: 27623308
[TBL] [Abstract][Full Text] [Related]
57. Graft-versus-leukemia reactions after bone marrow transplantation.
Horowitz MM; Gale RP; Sondel PM; Goldman JM; Kersey J; Kolb HJ; Rimm AA; Ringdén O; Rozman C; Speck B
Blood; 1990 Feb; 75(3):555-62. PubMed ID: 2297567
[TBL] [Abstract][Full Text] [Related]
58. Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse.
Singhal S; Powles R; Kulkarni S; Treleaven J; Saso R; Mehta J
Leuk Lymphoma; 1999 Feb; 32(5-6):505-12. PubMed ID: 10048423
[TBL] [Abstract][Full Text] [Related]
59. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
Champlin RE; Schmitz N; Horowitz MM; Chapuis B; Chopra R; Cornelissen JJ; Gale RP; Goldman JM; Loberiza FR; Hertenstein B; Klein JP; Montserrat E; Zhang MJ; Ringdén O; Tomany SC; Rowlings PA; Van Hoef ME; Gratwohl A
Blood; 2000 Jun; 95(12):3702-9. PubMed ID: 10845900
[TBL] [Abstract][Full Text] [Related]
60. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children.
Woolfrey AE; Anasetti C; Storer B; Doney K; Milner LA; Sievers EL; Carpenter P; Martin P; Petersdorf E; Appelbaum FR; Hansen JA; Sanders JE
Blood; 2002 Mar; 99(6):2002-8. PubMed ID: 11877272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
